|
|
 |
|
Viewing report
|
|
|
|
The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide
Research Facts Ltd, May 2009, Pages: 66
The modern history of drug delivery started with the founding of ALZA Corporation in 1968 by Dr. Alejandro Zaffaroni. His vision was to develop therapeutic systems that delivered drugs at controlled rates to the patient at the right site and right time. The impact of this approach in the field of medicine has been profound and its impact on the pharmaceutical business showed that major products could be produced in less time and for a smaller investment than a new chemical entity could.
The human brain is the single most common origin of illness, with 2 billion people
worldwide suffering from brain-related disease, causing an economic burden of $2 trillion a year. For the majority of patients no treatment exists or they are poorly treated by currently available therapies. Responding to this unmet medical need, the CNS disorders market became one of the largest and fastest growing markets in the pharmaceutical industry. In 2007, neuropharmaceutical companies alone generated $109 billion in revenues and looked forward to 8% annual growth.
There are many drug delivery technology companies worldwide. This report profiles the Top 35 with technologies for delivery to the central nervous system. These are the companies with the most innovative and effective products and technologies and the largest intellectual property estates.
Profile information for each company in The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide typically includes:
- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Address
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, Products, Technology, Therapeutic Indications, Intellectual Property Status, Parent Company, Year Established, Number of Employees and Turnover.
Author: The scientific advisor on this report was Katie Ryan. Katie has advanced degrees in physiology and medicine from Trinity College Dublin and is currently undertaking research in the Trinity College Institute of Neuroscience. Her main research interest is the use of Noradrenaline as a novel strategy to combat the neuroinflammation and neurodegeneration associated with conditions such as Alzheimer’s and Parkinson’s disease.
Report Target Market:
1) Drug Delivery Technology Companies
Usage: competitive/financial analysis and strategic partner/alliance identification
2) Pharmaceutical & Biotechnology Companies
This report is perfect for neuropharmaceutical and biotechnology companies who wish to identify leading, novel and proprietary central nervous system drug delivery technologies and know-how.
3) Contract Research & Manufacturing Organisations
The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide is useful to Contract Research & Manufacturing Organisations that provide services to biotechnology and pharmaceutical companies engaged in the development and manufacture of complex drug delivery systems, to identify new potential customers.
4) Academic Research Institutions
The report is also very helpful to academic research institutions interested in establishing research collaborations with central nervous system drug delivery technology companies, to investigate the potential of their technologies.
Note: Most people will be aware of some of the major drug delivery technology companies such as Elan Drug Technologies but this report looks at all 35 of the top companies with technologies for delivery to the central nervous system – companies like - to-BBB, a Leiden, the Netherlands headquartered company with two proprietary and safe platform technologies with unique applications in brain-targeted drug delivery.
Report data field structure is as follows:
Company Name
Mailing Address
Street Address
Telephone
Fax
Email
Website
Parent Company Name
Year Established
Number of Employees
Key Executives
Company Description
Products
Technology
Therapeutic Indications
Intellectual Property Status
Turnover €m
Location Status
Ownership
Research Facts is a world leader in life sciences publishing. It was established in Dublin, Ireland in 2004. Its partners have over forty years combined experience in the business information industry. Research Facts’ customers include most of the world’s major diagnostics, pharmaceutical, biotechnology and medical device companies e.g. Roche, Abbott, Quintiles, Johnson & Johnson, Wyeth, GlaxoSmithKline, Medtronic, Siemens Medical, Philips Healthcare, Thermo Fisher Scientific, Covance, GE Healthcare etc..
Research Facts’ reports help you make informed decisions about the markets and organisations that affect your business.
- Learn more about your target markets and target companies
- Top level research on all the major players in a market
- See which organisations dominate your major markets
- Get detailed information on particular organisations
Keywords:
Central Nervous System, CNS, Blood-Brain Barrier, BBB, Drug Delivery Technology, Pharmaceutical, Biotechnology.
Customers who bought this item also bought
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
The Top 40 Transdermal Drug Delivery Technology Companies Worldwide
The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System
Transdermal Drug Delivery - Technologies, Markets, and Companies
Drug Delivery in Cancer - Technologies, Markets and Companies
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Drug Delivery Technology - Revolutionizing CNS Therapies
Nanoparticle Drug Delivery Market Report
Drug Delivery Technology - Revolutionizing Cancer Therapies
Effective Deal Making in Drug Delivery
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report
Targeted Drug Delivery Technologies: Players, products & prospects to 2015
|
|
|
|
